ID   Sawano
AC   CVCL_4898
DR   CLO; CLO_0050872
DR   BioSample; SAMN03472162
DR   RCB; RCB1152
DR   Wikidata; Q54952146
RX   PubMed=8555123;
CC   Population: Japanese.
CC   Doubling time: 43.2 hours (Note=At 10th passage) (PubMed=8555123).
CC   Caution: Erroneously indicated as originating from a 67 year old patient in RCB=RCB1152.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): RCB=RCB1152
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12,13
ST   D16S539: 9,10
ST   D5S818: 9,12
ST   D7S820: 10,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 19,20,21
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
RX   PubMed=8555123;
RA   Satoh T., Nishida M., Miyazaki Y., Sugita M., Arai Y., Oki A.,
RA   Kono K., Tsunoda H., Kasahara K., Kubo T.;
RT   "Establishment of a cisplatin-resistant new human endometrial
RT   adenocarcinoma cell line, Sawano cells.";
RL   Hum. Cell 8:67-72(1995).
//